These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18376388)

  • 1. Cyclic nucleotide analogs as probes of signaling pathways.
    Poppe H; Rybalkin SD; Rehmann H; Hinds TR; Tang XB; Christensen AE; Schwede F; Genieser HG; Bos JL; Doskeland SO; Beavo JA; Butt E
    Nat Methods; 2008 Apr; 5(4):277-8. PubMed ID: 18376388
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
    Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
    Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP compartments and signaling specificity: role of cyclic nucleotide phosphodiesterases.
    Conti M; Mika D; Richter W
    J Gen Physiol; 2014 Jan; 143(1):29-38. PubMed ID: 24378905
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
    J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taming platelets with cyclic nucleotides.
    Schwarz UR; Walter U; Eigenthaler M
    Biochem Pharmacol; 2001 Nov; 62(9):1153-61. PubMed ID: 11705448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
    Butt E; Pöhler D; Genieser HG; Huggins JP; Bucher B
    Br J Pharmacol; 1995 Dec; 116(8):3110-6. PubMed ID: 8719784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds.
    Margarucci L; Roest M; Preisinger C; Bleijerveld OB; van Holten TC; Heck AJ; Scholten A
    Mol Biosyst; 2011 Jul; 7(7):2311-9. PubMed ID: 21597619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity.
    Meyer RB; Miller JP
    Life Sci; 1974 Mar; 14(6):1019-40. PubMed ID: 4362776
    [No Abstract]   [Full Text] [Related]  

  • 10. The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.
    Kumm EJ; Pagel O; Gambaryan S; Walter U; Zahedi RP; Smolenski A; Jurk K
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemotactic effect of cyclic AMP and its analogues in the Acrasieae.
    Konijn TM
    Antibiot Chemother (1971); 1974; 19():96-110. PubMed ID: 4377082
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of platelet PDE2 by an affinity label: 8-[(4-bromo-2, 3-dioxobutyl)thio]cAMP.
    Mseeh F; Colman RF; Colman RW
    Thromb Res; 2000 Jun; 98(5):395-401. PubMed ID: 10828479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endogenous Ca2+ channels by cyclic AMP and cyclic GMP-dependent protein kinases in Pleurodeles oocytes.
    Van Coppenolle F; Ahidouch A; Guilbault P; Ouadid H
    Mol Cell Biochem; 1997 Mar; 168(1-2):155-61. PubMed ID: 9062905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP activates BKCa channels in pulmonary arterial smooth muscle via cGMP-dependent protein kinase.
    Barman SA; Zhu S; Han G; White RE
    Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L1004-11. PubMed ID: 12547730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells.
    Cook AL; Haynes JM
    Cell Signal; 2004 Feb; 16(2):253-61. PubMed ID: 14636895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase regulation of alcohol drinking in rodents.
    Logrip ML
    Alcohol; 2015 Dec; 49(8):795-802. PubMed ID: 26095589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic GMP-dependent and cyclic AMP-dependent protein kinases, protein kinase modulators and phosphodiesterases in arteries and veins of dogs. Distribution and effects of arteriovenous fistula and arterial occlusion.
    Kuo JF; Malveaux EJ; Patrick JG; Davis CW; Kuo WN; Pruitt AW
    Biochim Biophys Acta; 1977 May; 497(3):785-96. PubMed ID: 196667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.
    Vandecasteele G; Verde I; Rücker-Martin C; Donzeau-Gouge P; Fischmeister R
    J Physiol; 2001 Jun; 533(Pt 2):329-40. PubMed ID: 11389195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phoshodiesterases. The ''lords of the ring'' meet IgA nephropathy].
    Ferraro PM
    G Ital Nefrol; 2010; 27(6):562. PubMed ID: 21132633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.